Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Ocular onchocerciasis in Israel]

T Oshry1, T Lifshitz, A Wender

  • 1Ophthalmology Dept., Soroka Medical Center, Beer Sheba.

Harefuah
|January 15, 1995
PubMed
Summary

Onchocerciasis, a parasitic disease causing blindness, affects millions globally. Early detection and annual Ivermectin treatment are crucial for managing this condition and preventing ocular destruction.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A review of anti-VEGF agents for proliferative diabetic retinopathy.

Eye (London, England)·2014
Same author

Molecular modeling of the liquid-vapor interfaces of a multi-component mixture: Prediction of the coexisting densities and surface tensions at different pressures and gas compositions.

The Journal of chemical physics·2013
Same author

Topical and systemic Ofloxacin (Tarivid) in the treatment of Gentamycin-resistant Pseudomonas corneal abscess.

Ocular immunology and inflammation·2012
Same author

Bilateral blurred vision after epidural corticosteroid injection.

Internal medicine journal·2011
Same author

Burkitt's lymphoma presenting as oculomotor palsy in an hiv-positive patient.

European journal of ophthalmology·2006
Same author

Brucella meningitis and papilledema in a child.

European journal of ophthalmology·2005

Area of Science:

  • Tropical Medicine
  • Infectious Diseases
  • Ophthalmology

Background:

  • Onchocerciasis, caused by Onchocerca volvulus, is a significant public health issue in endemic regions of Africa and South America.
  • The disease affects approximately 18 million people worldwide, leading to severe pruritus and potentially irreversible blindness.

Observation:

  • A case study of a 31-year-old Ethiopian immigrant in Israel highlights the diverse clinical manifestations of onchocerciasis.
  • This immigrant population presents various stages of the disease, underscoring the importance of recognizing its presence outside endemic areas.

Findings:

  • Ocular complications are a major concern, significantly reducing life expectancy in affected individuals.
  • Oral Ivermectin administered annually is identified as the safest and most effective treatment, crucial for disease management.

Implications:

  • Early diagnosis and prompt treatment are essential to prevent severe ocular destruction and long-term disability.
  • Public health strategies should consider the migration patterns of affected populations for effective disease control.

Related Experiment Videos